These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33803282)

  • 21. 5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: Comparison to terguride.
    Tawfik MK; Makary S
    Eur J Pharmacol; 2017 Nov; 814():114-123. PubMed ID: 28821451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis.
    Roh JS; Jeong H; Lee B; Song BW; Han SJ; Sohn DH; Lee SG
    Anim Cells Syst (Seoul); 2021; 25(6):387-395. PubMed ID: 35059138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition.
    Pei B; Zhang N; Pang T; Sun G
    Mol Cell Biochem; 2022 Apr; 477(4):995-1007. PubMed ID: 34988855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wenyang Huazhuo Tongluo formula alleviates pulmonary vascular injury and downregulates HIF-1α in bleomycin-induced systemic sclerosis mouse model.
    Li K; Wang Q; Lv Q; Guo K; Han L; Duan P; Deng Y; Bian H
    BMC Complement Med Ther; 2022 Jun; 22(1):167. PubMed ID: 35733188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
    Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y
    Arthritis Res Ther; 2015 May; 17(1):145. PubMed ID: 26025306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis.
    Bhattacharyya S; Wang W; Tamaki Z; Shi B; Yeldandi A; Tsukimi Y; Yamasaki M; Varga J
    Front Immunol; 2018; 9():2434. PubMed ID: 30405628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
    Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
    Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
    Russo RC; Alessandri AL; Garcia CC; Cordeiro BF; Pinho V; Cassali GD; Proudfoot AE; Teixeira MM
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):72-80. PubMed ID: 20833968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
    Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
    Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
    Kim S; Lim JH; Woo CH
    Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse model of experimental dermal fibrosis: the bleomycin-induced dermal fibrosis.
    Avouac J
    Methods Mol Biol; 2014; 1142():91-8. PubMed ID: 24706279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
    J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 38. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
    Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone Marrow-Derived Mesenchymal Stem Cells Expressing Thioredoxin 1 Attenuate Bleomycin-Induced Skin Fibrosis and Oxidative Stress in Scleroderma.
    Jiang M; Yu Y; Luo J; Gao Q; Zhang L; Wang Q; Zhao J
    J Invest Dermatol; 2017 Jun; 137(6):1223-1233. PubMed ID: 28132855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis.
    Kanno Y; Shu E; Kanoh H; Seishima M
    J Invest Dermatol; 2016 Apr; 136(4):762-769. PubMed ID: 26743600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.